The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Ziemssen T, Kern R, Cornelissen C
BMC Neurol. 2015; 15:93. Epub 2015 Jun 18. PMID: 26084334.Abstract